Patel, K., Kamal, A., Zhang, T., Schneider, A., Hamilton, E. P., & Peppercorn, J. M. (2011). The role of biologic therapy in phase II breast cancer clinical trials. In Journal of Clinical Oncology (Vol. 29, pp. e13048–e13048). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.e13048

Patel, K., A. Kamal, T. Zhang, A. Schneider, E. P. Hamilton, and J. M. Peppercorn. “The role of biologic therapy in phase II breast cancer clinical trials.” In Journal of Clinical Oncology, 29:e13048–e13048. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.e13048.

Patel K, Kamal A, Zhang T, Schneider A, Hamilton EP, Peppercorn JM. The role of biologic therapy in phase II breast cancer clinical trials. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. e13048–e13048.

Patel, K., et al. “The role of biologic therapy in phase II breast cancer clinical trials.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. e13048–e13048. Crossref, doi:10.1200/jco.2011.29.15_suppl.e13048.

Patel K, Kamal A, Zhang T, Schneider A, Hamilton EP, Peppercorn JM. The role of biologic therapy in phase II breast cancer clinical trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. e13048–e13048.